Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Schindler Holding Ltd.: Change to the Group Executive Committee
Schindler Holding Ltd.: Change to the Group Executive Committee
Schindler Holding Ltd.: Change to the Group Executive Committee
Stratus Properties Inc. Completes Sale of Lantana Place – Retail for $57.5 Million
Stratus Properties Inc. Completes Sale of Lantana Place – Retail for $57.5 Million


Stratus Properties Inc. (NASDAQ: STRS) (“Stratus”) today announced that it has completed the previously disclosed sale of its 100% owned, stabilized Lantana Place – Retail project for $57.5 million

Copart Reports First Quarter Fiscal 2026 Financial Results
Copart Reports First Quarter Fiscal 2026 Financial Results


Copart, Inc. (NASDAQ: CPRT) today reported financial results for the quarter ended October 31, 2025.



For the three months ended October 31, 2025, revenue, gross profit, and net income

GE HealthCare to acquire Intelerad, advancing cloud-enabled enterprise imaging across care settings
GE HealthCare to acquire Intelerad, advancing cloud-enabled enterprise imaging across care settings


GE HealthCare (Nasdaq: GEHC) announced it has entered into an agreement to acquire Intelerad, a leading medical imaging software provider for the healthcare industry, for a purchase price of $2.3

T-Mobile Extends Partnership with FORMULA 1 HEINEKEN LAS VEGAS GRAND PRIX, Expands Role as Regional 5G Innovation Partner of Formula 1®
T-Mobile Extends Partnership with FORMULA 1 HEINEKEN LAS VEGAS GRAND PRIX, Expands Role as Regional 5G Innovation Partner of Formula 1®


T-Mobile (NASDAQ: TMUS) today announced a multi-year extension as the Exclusive 5G Partner of the FORMULA 1 HEINEKEN LAS VEGAS GRAND PRIX and an expansion to become the Regional 5G Innovation

ABIONYX Pharma and SEBIA Announce an Exclusive Global Strategic Partnership to Transform Sepsis Diagnosis
ABIONYX Pharma and SEBIA Announce an Exclusive Global Strategic Partnership to Transform Sepsis Diagnosis


Regulatory News:



ABIONYX Pharma, (FR0012616852 – ABNX – eligible PEA PME), a next-generation biopharma company pioneering a new therapeutic era in sepsis and critical care through its

EQS-Adhoc: PIERER Mobility AG (to be renamed soon to Bajaj Mobility AG): Sale of FELT Bicycles to minority shareholders
EQS-Adhoc: PIERER Mobility AG (to be renamed soon to Bajaj Mobility AG): Sale of FELT Bicycles to minority shareholders
EQS-Adhoc: PIERER Mobility AG (to be renamed soon to Bajaj Mobility AG): Sale of FELT Bicycles to minority shareholders
Fuller, Smith & Turner PLC: Transaction in own shares
Fuller, Smith & Turner PLC: Transaction in own shares
Fuller, Smith & Turner PLC: Transaction in own shares
EQS-News: H2APEX: Strategic focus on expanding own hydrogen production capacities shows first positive effects – revenue forecast for full year 2025 raised
EQS-News: H2APEX: Strategic focus on expanding own hydrogen production capacities shows first positive effects – revenue forecast for full year 2025 raised
EQS-News: H2APEX: Strategic focus on expanding own hydrogen production capacities shows first positive effects – revenue forecast for full year 2025 raised
Funding Circle Holdings plc: POS-Transaction in Own Shares
Funding Circle Holdings plc: POS-Transaction in Own Shares
Funding Circle Holdings plc: POS-Transaction in Own Shares
EQS-News: Schweizer Electronic AG strengthens capital structure – focus on strategic development
EQS-News: Schweizer Electronic AG strengthens capital structure – focus on strategic development
EQS-News: Schweizer Electronic AG strengthens capital structure – focus on strategic development
EQS-Adhoc: H2APEX Group SCA: H2APEX raises revenue forecast for 2025
EQS-Adhoc: H2APEX Group SCA: H2APEX raises revenue forecast for 2025
EQS-Adhoc: H2APEX Group SCA: H2APEX raises revenue forecast for 2025
Cairn Homes Plc: Holding(s) in Company
Cairn Homes Plc: Holding(s) in Company
Cairn Homes Plc: Holding(s) in Company
EQS-Adhoc: Schweizer Electronic AG: Sells further shares in Schweizer Electronic (Jiangsu) Co., Ltd. and adjusts the forecast for the 2025 financial year
EQS-Adhoc: Schweizer Electronic AG: Sells further shares in Schweizer Electronic (Jiangsu) Co., Ltd. and adjusts the forecast for the 2025 financial year
EQS-Adhoc: Schweizer Electronic AG: Sells further shares in Schweizer Electronic (Jiangsu) Co., Ltd. and adjusts the forecast for the 2025 financial year
Morgan Stanley Sustainable Signals: Global Survey Shows Institutional Investors Maintain Positive Outlook on Sustainable Investing
Morgan Stanley Sustainable Signals: Global Survey Shows Institutional Investors Maintain Positive Outlook on Sustainable Investing


The majority of asset owners and managers globally expect allocations to sustainable funds to increase in the next two years, according to a new “Sustainable Signals” report by the Morgan Stanley

EQS-Adhoc: InTiCa Systems SE: Revised forecast for the 2025 financial year
EQS-Adhoc: InTiCa Systems SE: Revised forecast for the 2025 financial year
EQS-Adhoc: InTiCa Systems SE: Revised forecast for the 2025 financial year
Custodian Property Income REIT plc: Share Buyback
Custodian Property Income REIT plc: Share Buyback
Custodian Property Income REIT plc: Share Buyback
Intuit Appoints Enterprise AI Leader Bill McDermott and Financial Technology Innovator Adena Friedman to Board of Directors
Intuit Appoints Enterprise AI Leader Bill McDermott and Financial Technology Innovator Adena Friedman to Board of Directors


Intuit Inc. (Nasdaq: INTU), the global financial technology platform that makes Intuit TurboTax, Credit Karma, QuickBooks, and Mailchimp, today announced the appointment of Bill McDermott, Chairman

New Survey Offers Important Insights into How Medicare Advantage Beneficiaries Use and Value Their Supplemental Benefits
New Survey Offers Important Insights into How Medicare Advantage Beneficiaries Use and Value Their Supplemental Benefits


A recent study conducted by Humana Healthcare Research, with strategic input from researchers at the University of Pennsylvania, reveals key insights into how Medicare Advantage beneficiaries

Form 8.3 - Avadel Pharmaceuticals plc
Form 8.3 - Avadel Pharmaceuticals plc
Form 8.3 - Avadel Pharmaceuticals plc
U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer


Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved HYRNUO® (sevabertinib), an oral, reversible, tyrosine kinase inhibitor (TKI), for the treatment of adult patients